Please login to the form below

Not currently logged in
Email:
Password:

Sucampo moves on EU market

US pharmaceutical company, Sucampo, has launched a bid to compete in the European marketplace by filing a marketing authorisation application in Switzerland for its drug, Amitiza
US pharmaceutical company, Sucampo, has launched a bid to compete in the European marketplace by filing a marketing authorisation application (MAA) in Switzerland for its drug, Amitiza.

It has been developed for the treatment of chronic idiopathic constipation and is already available in the US. Sucampo hopes that it will soon be approved for use in Switzerland and is keen to build on what it has referred to as ëthe drug's success in the US' to extend its operations into the EU.

"We are systematically developing additional marketing opportunities outside the US," said Dr Ryuji Ueno, founder, chairman and CEO of Sucampo.

"This application is a continuation of these efforts as well as an ongoing expansion of our European operations."

The MAA has been submitted to SwissMedic, the regulatory body for medical products in Switzerland. The US Food and Drug Administration (FDA) first approved the drug for the treatment of chronic idiopathic constipation in adults in April 2006 and subsequently extended its uses for women suffering from irritable bowel syndrome (IBS) with constipation.

Nine other EU countries are currently reviewing MAAs for Amitiza, which were filed by Sucampo. Excluding the drug's marketing licence in the US, the company retains all commercial rights for the product in the whole of Europe and the rest of the world.

9th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics